Table 6.
Current study | Foundation for promotion of cancer research in Japan 2005 | Guideline of radiation therapy in Japan 2008 | The committee of gynecologic oncology of Japan 2004 | |
---|---|---|---|---|
3y OS | 3y OS | 5y OS | 5y OS | |
All stage | 69% | 81% | ||
Stage I | 100% | 90% | 80-90% | 82.3% |
Stage II | 73% | 83% | 60-80% | 61.4% |
Stage III | 57% | 65% | 40-60% | 37.6% |
Stage IV | 59% | 36% | (stage IVA) 10-40% | 12.6% |
OS – overall survival